KATIE BURLEN-DAVIS: Open Payments
NPI 1306485636 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$557 in 6 payments from 6 companies in 2025. Trend: 2023 $188 · 2024 $0 · 2025 $557
Food & beverage: $557
| Company | Payments | Amount |
|---|---|---|
| JAZZ PHARMACEUTICALS INC. | 1 | $125 |
| Stryker Corporation | 1 | $116 |
| Otsuka America Pharmaceutical, Inc. | 1 | $91 |
| GENZYME CORPORATION | 1 | $89 |
| SK Life Science, Inc. | 1 | $75 |
| Aimmune Therapeutics, Inc. | 1 | $61 |
Products named: XYWAV, FLOWTRIEVER CATHETER, S, REXULTI, XCOPRI, ZENPEP.
Industry payments across MI — which companies pay providers there.
